


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
HSMN NewsFeed - 28 Sep 2012
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and Marketing
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and Marketing
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 28 Sep 2012
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 26 Sep 2012
Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome
Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome
HSMN NewsFeed - 24 Sep 2012
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
HSMN NewsFeed - 21 Sep 2012
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
HSMN NewsFeed - 20 Sep 2012
Elan Announces the Appointment of Hans Peter Hasler as Chief Operating Officer
Elan Announces the Appointment of Hans Peter Hasler as Chief Operating Officer
HSMN NewsFeed - 20 Sep 2012
Cardiome Announces Appointment of Jennifer Archibald as Chief Financial Officer
Cardiome Announces Appointment of Jennifer Archibald as Chief Financial Officer
HSMN NewsFeed - 18 Sep 2012
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
HSMN NewsFeed - 18 Sep 2012
Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
HSMN NewsFeed - 17 Sep 2012
Cook Pharmica Names Victor Vinci Vice President and Chief Scientific Officer
Cook Pharmica Names Victor Vinci Vice President and Chief Scientific Officer
HSMN NewsFeed - 14 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
HSMN NewsFeed - 14 Sep 2012
Bayer HealthCare To Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries
Bayer HealthCare To Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries
HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
HSMN NewsFeed - 13 Sep 2012
Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
HSMN NewsFeed - 10 Sep 2012
Merck Announces New Phase III Data for Suvorexant, an Investigational Insomnia Medicine
Merck Announces New Phase III Data for Suvorexant, an Investigational Insomnia Medicine
HSMN NewsFeed - 10 Sep 2012
A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development
A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 7 Sep 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
HSMN NewsFeed - 6 Sep 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda
Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda
HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
HSMN NewsFeed - 30 Aug 2012
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
HSMN NewsFeed - 22 Aug 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
HSMN NewsFeed - 22 Aug 2012
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
HSMN NewsFeed - 21 Aug 2012
Inspiration Biopharmaceuticals Announces New Global Commercialization Agreements with Ipsen
Inspiration Biopharmaceuticals Announces New Global Commercialization Agreements with Ipsen
HSMN NewsFeed - 16 Aug 2012
Threshold Pharmaceuticals Appoints Laura G. Hansen, Ph.D., Senior Director, Corporate Communications
Threshold Pharmaceuticals Appoints Laura G. Hansen, Ph.D., Senior Director, Corporate Communications
HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
HSMN NewsFeed - 14 Aug 2012
Pharmacyclics(R) Appoints Joshua T. Brumm Executive Vice President of Finance
Pharmacyclics(R) Appoints Joshua T. Brumm Executive Vice President of Finance
HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
